$AGEN·8-K

AGENUS INC · Jul 6, 4:10 PM ET

Compare

AGENUS INC 8-K

Research Summary

AI-generated summary

Updated

Agenus Inc. Extends 2015 Notes and Issues New 2026 D Warrants

What Happened

  • On June 29, 2026 (filed 8‑K July 6, 2026), Agenus Inc. announced an Amendment to Notes, Extension of Warrants and Sale of New Warrants with existing noteholders. The Company extended the maturity date of $5.09 million of its 2015 senior subordinated promissory notes from June 20, 2026 to February 18, 2027; all other note terms (including interest rate) remain unchanged.
  • The amendment also extended the expiration dates of previously issued warrants (2022 A, 2022 B and 2025 C) to June 25, 2031 and issued new 2026 D Warrants to certain noteholders to purchase an aggregate of 56,525 shares of common stock at an exercise price of $3.25 per share, expiring June 25, 2031. Agenus will register the shares issuable upon exercise of the New D Warrants with the SEC within 90 days of June 29, 2026. The securities were issued under a private placement exemption (Section 4(2)) and are unregistered.

Key Details

  • Debt extension: $5.09 million of 2015 senior subordinated notes — maturity moved 8 months to Feb 18, 2027; interest rate unchanged.
  • Warrants extended: Amended A (65,000 shares), Amended B (32,500 shares), Amended C (67,500 shares) — all expirations now June 25, 2031; exercise price $3.25.
  • New issuance: 2026 D Warrants for 56,525 shares at $3.25/share, expiring June 25, 2031; company to register underlying shares within 90 days.
  • Aggregate warrants affected: 221,525 shares (165,000 previously issued warrants extended; 56,525 newly issued). Securities are unregistered and subject to transfer restrictions.

Why It Matters

  • Short-term funding relief: Extending the maturity of the $5.09M notes by eight months reduces immediate refinancing pressure or default risk tied to the June 2026 maturity date. No change was made to interest rates.
  • Potential dilution: The amendment extends the life of existing warrants and adds new warrants that could dilute common shareholders if exercised (exercise price $3.25). The company’s commitment to register the New D underlying shares within 90 days may make resale easier for holders once the registration is effective.
  • Transaction structure: Securities were issued in a private placement (unregistered) under Section 4(2), so transfers and sales are restricted unless registered or exempt.

Loading document...